Found: 191
Select item for more details and to access through your institution.
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 392, doi. 10.1007/s10637-021-01185-4
- By:
- Publication type:
- Article
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 8, p. 753, doi. 10.1111/hepr.14025
- By:
- Publication type:
- Article
Concordance between metabolic dysfunction‐associated steatotic liver disease and nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 600, doi. 10.1111/hepr.14011
- By:
- Publication type:
- Article
Safety and effectiveness of lusutrombopag in patients who have chronic liver disease with thrombocytopenia and undergoing invasive procedures: Real‐world post‐marketing surveillance in Japan.
- Published in:
- Hepatology Research, 2023, v. 53, n. 11, p. 1105, doi. 10.1111/hepr.13945
- By:
- Publication type:
- Article
Report of the 23rd nationwide follow‐up survey of primary liver cancer in Japan (2014–2015).
- Published in:
- Hepatology Research, 2023, v. 53, n. 10, p. 895, doi. 10.1111/hepr.13953
- By:
- Publication type:
- Article
Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.
- Published in:
- Hepatology Research, 2023, v. 53, n. 3, p. 238, doi. 10.1111/hepr.13860
- By:
- Publication type:
- Article
Reevaluation of Makuuchi's criteria for resecting hepatocellular carcinoma: A Japanese nationwide survey.
- Published in:
- Hepatology Research, 2023, v. 53, n. 2, p. 127, doi. 10.1111/hepr.13844
- By:
- Publication type:
- Article
Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B.
- Published in:
- Hepatology Research, 2023, v. 53, n. 1, p. 35, doi. 10.1111/hepr.13839
- By:
- Publication type:
- Article
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 1, p. 61, doi. 10.1111/hepr.13836
- By:
- Publication type:
- Article
Impact of antiviral therapy for disease progression and non‐invasive liver fibrosis index in patients with chronic hepatitis C: Markov chain model analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 8, p. 665, doi. 10.1111/hepr.13794
- By:
- Publication type:
- Article
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2022, v. 52, n. 6, p. 497, doi. 10.1111/hepr.13764
- By:
- Publication type:
- Article
Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1181, doi. 10.1111/hepr.13715
- By:
- Publication type:
- Article
Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1170, doi. 10.1111/hepr.13684
- By:
- Publication type:
- Article
Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1172, doi. 10.1111/hepr.13700
- By:
- Publication type:
- Article
Prognosis of intrahepatic cholangiocarcinoma stratified by albumin–bilirubin grade.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 902, doi. 10.1111/hepr.13673
- By:
- Publication type:
- Article
Evidence‐based clinical practice guidelines for liver cirrhosis 2020.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 725, doi. 10.1111/hepr.13678
- By:
- Publication type:
- Article
Treatment of hepatocellular carcinoma during the COVID‐19 outbreak: The Working Group report of JAMTT‐HCC.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1004, doi. 10.1111/hepr.13541
- By:
- Publication type:
- Article
Advanced fibrosis leads to overestimation of steatosis with quantitative ultrasound in individuals without hepatic steatosis.
- Published in:
- Ultrasonography, 2024, v. 43, n. 2, p. 121, doi. 10.14366/usg.23194
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 275, doi. 10.1159/000515553
- By:
- Publication type:
- Article
Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 249, doi. 10.1159/000514420
- By:
- Publication type:
- Article
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 583, doi. 10.1159/000508724
- By:
- Publication type:
- Article
IEEE 802.11n Physical Layer Implementation on Field Programmable Gate Array.
- Published in:
- Telkomnika, 2012, v. 10, n. 1, p. 67, doi. 10.12928/telkomnika.v10i1.761
- By:
- Publication type:
- Article
Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198812
- By:
- Publication type:
- Article
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194704
- By:
- Publication type:
- Article
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3349, doi. 10.1093/cid/ciaa1307
- By:
- Publication type:
- Article
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 17, p. 3507, doi. 10.1093/hmg/ddr249
- By:
- Publication type:
- Article
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0265235
- By:
- Publication type:
- Article
The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0264075
- By:
- Publication type:
- Article
A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- Internal Medicine, 2024, v. 63, n. 9, p. 1185, doi. 10.2169/internalmedicine.2248-23
- By:
- Publication type:
- Article
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
- Published in:
- Internal Medicine, 2023, v. 62, n. 7, p. 973, doi. 10.2169/internalmedicine.0212-22
- By:
- Publication type:
- Article
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 1, p. 40, doi. 10.3390/ijms22010040
- By:
- Publication type:
- Article
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-Fetoprotein as a Long-Term Hepatocellular Carcinoma Predictor.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3640, doi. 10.3390/ijms21103640
- By:
- Publication type:
- Article
Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 8, p. 996, doi. 10.1111/hepr.13533
- By:
- Publication type:
- Article
Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Hepatology Research, 2020, v. 50, n. 1, p. 137, doi. 10.1111/hepr.13416
- By:
- Publication type:
- Article
Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen.
- Published in:
- Hepatology Research, 2019, v. 49, n. 10, p. 1121, doi. 10.1111/hepr.13387
- By:
- Publication type:
- Article
Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group.
- Published in:
- Hepatology Research, 2019, v. 49, n. 10, p. 1114, doi. 10.1111/hepr.13362
- By:
- Publication type:
- Article
Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
- Published in:
- Hepatology Research, 2019, v. 49, n. 3, p. 264, doi. 10.1111/hepr.13246
- By:
- Publication type:
- Article
Non‐invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infection.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 33, doi. 10.1111/hepr.13286
- By:
- Publication type:
- Article
Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus.
- Published in:
- Hepatology Research, 2018, v. 48, n. 13, p. 1131, doi. 10.1111/hepr.13233
- By:
- Publication type:
- Article
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.
- Published in:
- Hepatology Research, 2018, v. 48, n. 9, p. 746, doi. 10.1111/hepr.13070
- By:
- Publication type:
- Article
Up‐to‐seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child–Pugh grade deterioration after initial conventional transarterial chemoembolization.
- Published in:
- Hepatology Research, 2018, v. 48, n. 6, p. 442, doi. 10.1111/hepr.13048
- By:
- Publication type:
- Article
Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post-marketing surveillance of tolvaptan in liver cirrhosis (START study).
- Published in:
- Hepatology Research, 2017, v. 47, n. 11, p. 1137, doi. 10.1111/hepr.12852
- By:
- Publication type:
- Article
Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies.
- Published in:
- Hepatology Research, 2016, v. 46, n. 10, p. 992, doi. 10.1111/hepr.12638
- By:
- Publication type:
- Article
Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group.
- Published in:
- Hepatology Research, 2016, v. 46, n. 4, p. 251, doi. 10.1111/hepr.12515
- By:
- Publication type:
- Article
JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.
- Published in:
- Hepatology Research, 2016, v. 46, n. 2, p. 129, doi. 10.1111/hepr.12645
- By:
- Publication type:
- Article
Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy.
- Published in:
- Hepatology Research, 2015, v. 45, n. 10, p. E115, doi. 10.1111/hepr.12474
- By:
- Publication type:
- Article
Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients.
- Published in:
- Hepatology Research, 2015, v. 45, n. 10, p. E82, doi. 10.1111/hepr.12466
- By:
- Publication type:
- Article
Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy.
- Published in:
- Hepatology Research, 2015, v. 45, n. 8, p. 872, doi. 10.1111/hepr.12427
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications.
- Published in:
- Hepatology Research, 2015, v. 45, n. 6, p. 667, doi. 10.1111/hepr.12405
- By:
- Publication type:
- Article
Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging.
- Published in:
- Hepatology Research, 2014, v. 44, n. 13, p. 1339, doi. 10.1111/hepr.12309
- By:
- Publication type:
- Article